Skip to main content
RCKT logo

RCKT · Rocket Pharmaceuticals, Inc.

$3.44 +0.03 (+0.88%) At close · Jul 17
Market Cap
$375.63M
Shares
109.19M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-07 Malik Fady Ibraham 10,670
2026-05-21 Shah Gaurav 55,684
2026-05-19 Militello John 384
2026-05-19 Wilson Martin 662
2026-05-19 Shah Gaurav 2,409
2026-05-13 Wilson Martin 3,361
2026-05-13 Shah Gaurav 2,728
2026-05-13 Militello John 855
2026-05-07 Chaudhuri Sarbani 17,650
2026-02-18 Shah Gaurav 5,990
2026-02-18 Militello John 1,157
2026-02-18 Wilson Martin 1,376
2026-02-13 Militello John 3,726
2026-02-13 Schwartz Jonathan David 14,508
2026-02-13 Shah Gaurav 12,279
2026-02-13 Wilson Martin 12,253
2025-11-18 Shah Gaurav 6,276
2025-11-18 Schwartz Jonathan David 2,545
2025-11-18 Militello John 1,086
2025-11-18 Wilson Martin 1,646
2025-10-14 Militello John 28,918
2025-08-19 Wilson Martin 588
2025-08-19 Militello John 361
2025-08-19 Schwartz Jonathan David 805
2025-08-18 Wilson Martin 1,004
2025-08-18 Militello John 699
2025-08-18 Schwartz Jonathan David 1,680
2025-08-14 Wilson Martin 12,109
2025-08-14 Militello John 7,043
2025-08-14 Schwartz Jonathan David 11,161
2025-07-03 Ondrey Aaron 1,477
2025-05-20 Shah Gaurav 2,253
2025-05-20 Patel Kinnari 767
2025-05-20 Schwartz Jonathan David 801
2025-05-20 Wilson Martin 587
2025-05-20 Militello John 357
2025-05-16 Militello John 655
2025-05-16 Schwartz Jonathan David 1,582
2025-05-16 Patel Kinnari 1,409
2025-05-16 Shah Gaurav 3,621
2025-05-16 Wilson Martin 946
2025-04-22 Militello John 718
2025-04-09 White Mark Andrew 3,382
2025-04-04 Ondrey Aaron 7,489
2025-02-25 Schwartz Jonathan David 6,532
2025-02-21 Shah Gaurav 16,303
2025-02-21 Militello John 2,737
2025-02-21 White Mark Andrew 1,222
2025-02-21 Patel Kinnari 6,078
2025-02-21 Wilson Martin 3,222
Showing 1–50 of 97 filings
Key facts CIK 1281895 CUSIP 77313F106 13F (30d) 14 filings 13 filers Visit website Investor relations